- Change for America on Science and Tech Policy: Part 1
- Taking a Short Break
- Transition Team Deploys Its First Public Web 2.0 Tools
- Victory for Stem Cells in Michigan
- White Open Spaces
- Historical Election Maps and Open Mapping Research
- Scary Regulatory Maneuvers in Bush’s Last Days
- FDA Did Not Finish Its Homework On BPA
- Digital Freedom of Expression and Human Rights
- Traumatic Brain Injury and Helmet Design
- Gates Foundation Funds Research, Venture Capital Style
- A Brief History of Lead Regulation
End-of-the-Week Review: Anthrax, Booger, Carbon, and Drugs
Some of the interesting blogs that caught our attention this week:
Effect Measure goes where few other dare and questions the validity of the Ivins fiasco, not once but twice this week. The evidence is the same as what the mainstream media presents, but the authors arrive at a different conclusion from the FBI’s.
Joe Romm, writing at Science Blog’s Next Generation of Energy Ideas blog, explains that if we don’t stem the flood of carbon pouring out of coal-fired power plants, nothing else we do to stop climate change will matter.
Mira Kolodkin at SEA’s blog covers the FDA’s inability to adequately follow up on illegal uses of drugs and comments on the GAO’s suggestion of a tracking system to help the FDA respond to complaints of violations more efficiently.
Brandon Keim at Wired touches on the bioethical implications of cloning Booger and comments on misconceptions about personhood. He explains that Booger, like people, was more than his genes.
Comments on this article

